Cyclophosphamide in the therapy of multiple sclerosis
Salvatores, U.; Majeron, M.; Mascetti, A.
Rivista Sperimentale di Freniatria e Medicina Legale Delle Alienazioni Mentali 96(1): 163-184
1972
ISSN/ISBN: 0370-7261 PMID: 4337775 Document Number: 49023
Document emailed within 1 workday
Related Documents
Watanabe, T.; Yamamoto, T.; Saito, T.; Sugano, M.; Tsukamoto, T. 1993: Pulse-dose cyclophosphamide therapy for chronic progressive multiple sclerosis Rinsho Shinkeigaku 33(1): 15-20Ikeda, T.; Kagitani-Shimono, K.; Iwatani, Y.; Kitai, Y.; Tachibana, M.; Tominaga, K.; Okinaga, T.; Nagai, T.; Ozono, K. 2013: Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report No to Hattatsu 45(1): 49-52
Trouillas, P.; Neuschwander, P.; Nighoghossian, N.; Adeleine, P.; Tremisi, P. 1989: Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years Revue Neurologique (Paris) 145(5): 369-377
Zephir, H.; De-Seze, J.; Senechal, O.; Stojkovic, T.; Ferriby, D.; Delisse, B.; Dubus, B.; Verier, A.; Hautecoeur, P.; Vermersch, P. 2002: Treatment of progressive multiple sclerosis with cyclophosphamide Revue Neurologique (Paris) 158(1): 65-69
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1988: Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 22(5): 399-403
Wender, M.; Michałowska, G. 1986: IgG synthesis in the cerebrospinal fluid in patients with the chronic progressive phase of multiple sclerosis treated with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 20(6): 536-541
Carter, J.L.; Hafler, D.A.; Dawson, D.M.; Orav, J.; Weiner, H.L. 1988: Immunosuppression with high-dose I.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients Neurology 38(7 Suppl 2: 9-14
Iwata, N.; Miyamae, T.; Imagawa, T.; Katakura, S.; Mori, M.; Aihara, Y.; Yokota, S.; Kondo, M.; Sasaki, T.; Ikezawa, Y. 2003: Cyclophosphamide pulse therapy for pediatric systemic sclerosis Ryumachi 43(4): 660-666
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
Silver, R.M.; Warrick, J.H.; Kinsella, M.B.; Staudt, L.S.; Baumann, M.H.; Strange, C. 1993: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease Journal of Rheumatology 20(5): 838-844
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Shih, W.W.; Baumhefner, R.W.; Tourtellotte, W.W.; Haskell, C.M.; Korn, E.L.; Fahey, J.L. 1983: Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis Clinical and Experimental Immunology 53(1): 122-132
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Wilson, K.; Shelley, W.; Belch, A.; Brandes, L.; Bergsagel, D.; Klimo, P.; White, D.; Willan, A. 1987: Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma Cancer Treatment Reports 71(10): 981-982
Simó, M. 2009: Therapy of multiple sclerosis Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 11(1): 23-26
Kesselring, J. 1984: Therapy of multiple sclerosis Schweizerische Medizinische Wochenschrift 114(35): 1186-1190
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Csépány, T.ün.; Bereczki, D.án. 2004: Immunomodulatory therapy in multiple sclerosis Ideggyogyaszati Szemle 57(11-12): 401-416